(Q39653852)

13 September 2017

title

Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway (English)

1 reference

13 September 2017

Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: Involvement of SIRT1 and TGF-β1 pathway (English)

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

16 July 2024

1 reference

Cairong Li

1

1 reference

13 September 2017

Fei Cai

2

1 reference

13 September 2017

Yinqiao Yang

3

1 reference

13 September 2017

Xinyuan Zhao

4

1 reference

13 September 2017

Chun Wang

5

1 reference

13 September 2017

Juan Li

6

1 reference

13 September 2017

Yanlong Jia

7

1 reference

13 September 2017

Jing Tang

8

1 reference

13 September 2017

Qing Liu

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

18 September 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0014299910008848?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

https://api.elsevier.com/content/article/PII:S0014299910008848?httpAccept=text/plain

16 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

European Journal of Pharmacology

16 July 2024

published in

1 reference

13 September 2017

volume

649

1 reference

13 September 2017

issue

1-3

1 reference

13 September 2017

page(s)

382-389

1 reference

Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy.

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

16 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Redox modulation of long-term potentiation in the hippocampus via regulation of the glycogen synthase kinase-3beta pathway

16 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

16 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose.

16 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

16 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Diabetic nephropathy: mechanisms of renal disease progression

16 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

16 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats

16 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation

16 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation

16 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

16 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis

16 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

16 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history

16 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines

16 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

TGF-beta in diabetic kidney disease: role of novel signaling pathways

16 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse

16 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

16 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

The Sir2 protein family: A novel deacetylase for gene silencing and more

16 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy

16 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia

16 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation.

16 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

16 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

16 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

16 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Inhibitory effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside on experimental inflammation and cyclooxygenase 2 activity

16 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

16 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.004

16 July 2024

Identifiers

1 reference

13 September 2017

1 reference